Le Lézard
Classified in: Science and technology, Business
Subject: PER

Buck Appoints David Gillen as Health Practice Analytics Leader


NEW YORK, Dec. 13, 2018 /PRNewswire/ -- Buck, an integrated HR and benefits consulting, administration, and technology services firm, today announced that David Gillen, a Principal in Buck's Pittsburgh office, has been appointed to the Health Practice as Analytics Leader.

In this role, Gillen will lead a best-in-class health analytics function at Buck and provide executive level consulting in analytics to identify and drive winning data strategies with clients.

Gillen previously led the growth and expansion of Innovu, Inc. from a startup to a significant national analytics player as VP of Partner and client relationships. Prior to joining Innovu, Gillen worked in the benefits consulting industry, most recently as a consultant at Willis Towers Watson where he focused on large, self-funded employers.

"A deep understanding of the data harnessed from both traditional and disparate sources can significantly improve a company's HR infrastructure and drive positive outcomes with its stakeholders," said Gillen. "I'm excited to broaden the insights we bring to clients and help them realize even greater business results through a purpose-driven approach to industry-leading data and analytics. Buck is making the right technology investments to drive real change for our clients."

"In addition to his track record with clients, David's hands-on experience building, designing, and implementing analytics solutions across the entire HR spectrum gives us a leg up on our competition," said Dean Aloise, Managing Director, US of Buck. "We are very excited to bring David's considerable expertise in-house."

Gillen holds a bachelor's degree in Managerial Economics from Allegheny College and is finishing his master's degree at the Joseph M. Katz Graduate School of Business at the University of Pittsburgh.

About Buck

Buck is an integrated HR and benefits consulting, administration, and technology services provider. Headquartered in New York City, with global operations, Buck is focused on helping its clients realize the best organizational performance for their business while driving positive health, wealth and career outcomes for their people. For additional information, visit www.buck.com.

Media contact: 
Lumina Communications for Buck 
Michael Gallo 
212-239-8594 
[email protected]

(PRNewsfoto/Buck)

SOURCE Buck


These press releases may also interest you

at 17:59
Spectrum Control Inc. announces a revolutionary new Direct RF extension to its SCi Blocks family of miniature, modular, and intelligent RF+Digitaltm system building blocks. This new DirectRF+tm module enables customers to rapidly deploy configurable...

at 17:58
Australia-based company Hysata is developing new high-efficiency electrolysers that aim to produce green hydrogen at scale with higher energy efficiency and lower costs than alternative technologies. The company's technology combines engineering and...

at 17:45
Cheney Bros Inc., a leading family-owned and operated broadline food distributor serving the Southeastern United States, is pleased to announce a strategic partnership with Cut+Dry, the foodservice industry's premier e-commerce platform. This...

at 17:35
kneat.com, inc. ("Kneat" or the "Company") a leader in digitizing and automating validation and quality processes, today announced financial results for the three-month period ended March 31, 2024. All dollar amounts are presented in Canadian...

at 17:35
The global underwater camera market size is estimated to grow by USD 3.64 billion from 2023 to 2027, according to Technavio. This growth is expected to occur at a Compound Annual Growth Rate (CAGR) of almost 11.68% during the forecast period....

at 17:30
PT217 is Phanes' first-in-class bispecific antibody targeting DLL3 and CD47; atezolizumab (TECENTRIQ®) is Roche's anti-PD-L1 monoclonal antibodyThe clinical supply agreement will focus on evaluating PT217 in combination with atezolizumab for the...



News published on and distributed by: